The mechanism underlying the improvement in NAFLD by STE was elucidated in a follow-up study which highlighted its regulation of the AMPK and Nrf2-Keap1 signaling pathways. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.